The Development and Internal Evaluation of a Predictive Model to Identify for Whom Mindfulness-Based Cognitive Therapy Offers Superior Relapse Prevention for Recurrent Depression Versus Maintenance Antidepressant Medication
Overview
This paper presents a study developing predictive models to help adults with recurrent depression choose between maintenance antidepressant medication and mindfulness-based cognitive therapy for relapse prevention. The authors analyzed data from 424 participants to identify which demographic, clinical, or psychological factors best predicted outcomes over 24 months. The resource is intended for researchers and clinicians interested in evidence-based decision-making tools for treatment selection.
- ID
623cab6c1edf4a37- Source org
- OpenAlex
- Author
- Zachary D. Cohen (University of California, Los Angeles), Robert J. DeRubeis (University of Pennsylvania), Rachel Hayes (University of Exeter), Edward Watkins (University of Exeter), Glyn Lewis (University College London), Richard Byng (National Institute for Health and Care Research), Sarah Byford (King's College London), Catherine Crane (University of Oxford), Willem Kuyken (University of Oxford), Tim Dalgleish (MRC Cognition and Brain Sciences Unit), Susanne Schweizer (University of Cambridge)
- Published
- 2022-04-29
- OA status
- hybrid
- DOI
- 10.1177/21677026221076832
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 23
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkblocked via http-check · 2026-07-28T05:51:39.503185+00:00
Cite this entry
BibTeX
@article{allodium:623cab6c1edf4a37,
title = {The Development and Internal Evaluation of a Predictive Model to Identify for Whom Mindfulness-Based Cognitive Therapy Offers Superior Relapse Prevention for Recurrent Depression Versus Maintenance Antidepressant Medication},
author = {Zachary D. Cohen and Robert J. DeRubeis and Rachel Hayes and Edward Watkins and Glyn Lewis and Richard Byng and Sarah Byford and Catherine Crane and Willem Kuyken and Tim Dalgleish and Susanne Schweizer},
year = {2022},
journal = {OpenAlex},
doi = {10.1177/21677026221076832},
url = {https://doi.org/10.1177/21677026221076832}
}RIS
TY - JOUR TI - The Development and Internal Evaluation of a Predictive Model to Identify for Whom Mindfulness-Based Cognitive Therapy Offers Superior Relapse Prevention for Recurrent Depression Versus Maintenance Antidepressant Medication AU - Cohen, Zachary D. AU - DeRubeis, Robert J. AU - Hayes, Rachel AU - Watkins, Edward AU - Lewis, Glyn AU - Byng, Richard AU - Byford, Sarah AU - Crane, Catherine AU - Kuyken, Willem AU - Dalgleish, Tim AU - Schweizer, Susanne PY - 2022 PB - OpenAlex DO - 10.1177/21677026221076832 UR - https://doi.org/10.1177/21677026221076832 ER -
APA
Cohen, Z. D., DeRubeis, R. J., Hayes, R., Watkins, E., Lewis, G., Byng, R., Byford, S., Crane, C., Kuyken, W., Dalgleish, T., & Schweizer, S. (2022). The Development and Internal Evaluation of a Predictive Model to Identify for Whom Mindfulness-Based Cognitive Therapy Offers Superior Relapse Prevention for Recurrent Depression Versus Maintenance Antidepressant Medication. OpenAlex. https://doi.org/10.1177/21677026221076832
Related entries
- The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study)
- Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study
- Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: Randomised controlled non-inferiority trial
- Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial
- Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse
- Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial
- Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression
- Mindfulness‐based cognitive therapy for prevention and time to depressive relapse: Systematic review and network meta‐analysis
- Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.
- Effectiveness of mindfulness-based cognitive therapy on the management of depressive disorder: Systematic review